Video

Anthony Feinstein: Improving Treatment and Education of Depression and Cognition in Multiple Sclerosis

Author(s):

There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.

There is still much more to be learned about the effects of depression and cognitive impairment in patients with multiple sclerosis but there are steps being taken to address these issues and help better inform patients of the impact both can play in their lives.

Working at the University of Toronto Anthony Feinstein, MD, PhD, has been working on learning more about both of these areas but said there is much more work to be done as his research continues. Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Feinstein said it is important for doctors to have what can be a difficult discussion with their patients about these issues to help them prepare for what could potentially be in their future.

Related Videos
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.